Sutro Biopharma (STRO) Non-cash Items (2016 - 2025)

Sutro Biopharma has disclosed Non-cash Items across 10 years of filings, most recently posting $1.2 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.2 million (changed N/A YoY), and the FY2025 annual result was $1.2 million, down 80.8% from the prior year.
• Non-cash Items came in at $1.2 million for Q4 2025 at Sutro Biopharma, down from $5.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $58.1 million in Q1 2021 to a low of $180000.0 in Q4 2023.
• The 5-year median for Non-cash Items is $5.5 million (2023), against an average of $9.4 million.
• Across the five-year window, Non-cash Items tumbled 92.88% in 2022 and surged 2175.81% in 2023, its largest moves.
• Sutro Biopharma's Non-cash Items stood at $15.0 million in 2021, then tumbled by 85.38% to $2.2 million in 2022, then plunged by 91.77% to $180000.0 in 2023, then soared by 3427.65% to $6.3 million in 2024, then slumped by 80.72% to $1.2 million in 2025.
• The last three Non-cash Items figures came in at $1.2 million (Q4 2025), $5.2 million (Q3 2025), and $6.6 million (Q2 2025), per Business Quant data.